Coronavirus Disease 2019 (COVID-19)最新文献_第5页

“Healthcare at its finest”: Patient perspectives on virtual care appointments in primary care “最好的医疗保健”:患者对初级保健中虚拟护理预约的看法

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-03-01 DOI: 10.1370/afm.20.s1.2944

Rachelle Ashcroft, B. Ryan, Kavita Mehta, J. Brown, Simon Lam, L. Dolovich, Amélie Boudreault, J. Rayner, J. Grenier, S. Dahrouge, Sally Abudiab, Sandeep Gill, C. Donnelly, J. Alloo, D. Verrilli

{"title":"“Healthcare at its finest”: Patient perspectives on virtual care appointments in primary care","authors":"Rachelle Ashcroft, B. Ryan, Kavita Mehta, J. Brown, Simon Lam, L. Dolovich, Amélie Boudreault, J. Rayner, J. Grenier, S. Dahrouge, Sally Abudiab, Sandeep Gill, C. Donnelly, J. Alloo, D. Verrilli","doi":"10.1370/afm.20.s1.2944","DOIUrl":"https://doi.org/10.1370/afm.20.s1.2944","url":null,"abstract":"Context: COVID-19 led to a rapid uptake of virtual care appointments (telephone and video) in primary care (PC). Decisions on the future of virtual care need to consider patien ts’ experiences. Objective: To understand patients’ experience with virtual care appointments. Study Design: Mixed methods study, presentation focus on qualitative data. A semi-structured interview guide was co-created with patient advisors. A broad recruitment strategy included emailing patient and community organizations, research team network, and social media. Data analyzed using thematic analysis. Participant Eligibility: At least one synchronous virtual encounter in PC since March 2020. Setting: Ontario (Canada) offers universal coverage for PC visits with no co-payment. Results: N=55 interviews were conducted between January 2021 and March 2021. Technology: Telephone was preferred modality. Access: Virtual care was convenient and saved patients’ time and money. Appointment scheduling & booking processes were barriers. Privacy and Confidentiality: No concerns about privacy & confidentiality in patients’ environment, yet participants wanted assurance about privacy & confidentiality in providers’ environm ent. Communication: Providers’ detailed explanations, patients’ health literacy levels, and asynchronous methods of sharing information and documents before and/or after appointments facilitated good experiences. Lack of body-language was a barrier. Therapeutic Relationship: Strong pre-existing relationships facilitated good virtual care experiences. Participants expressed concerns about long-term erosion of relationship when using virtual care. Whole-Person Care: Virtual care facilitated easy inclusion of family members in appointments. However, virtual care appointments were more problem-focused and included less conversation topics outside of specific problem","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84769431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Clinical Trials of COVID-19 Therapeutics and Vaccines COVID-19疗法和疫苗的临床试验

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-14

Candan Hizel Perry, H. Ö. Kılgöz, S. Tüzmen

引用次数: 0

Application of Stem Cell and Exosome-Based Therapy in COVID-19 干细胞和外泌体治疗在COVID-19中的应用

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-9

S. Kara, A. Sariboyaci

引用次数: 0

Drug Repurposing and Novel Antiviral Drugs for COVID-19 Management 药物再利用和新型抗病毒药物用于COVID-19管理

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-7

Shailendra Dwivedi, A. Rawat, A. Ranjan, Ruchika Agrawal, Radhieka Misra, S. Gupta, S. Kishore, S. Misra

引用次数: 0

Nanomaterials in COVID-19 Drug Development 纳米材料在COVID-19药物开发中的应用

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-12

A. Aljabali, Ã. Serrano-Aroca, K. Lundstrom, M. Tambuwala

引用次数: 0

Host and Pathogen-Specific Drug Targets in COVID-19 COVID-19中宿主和病原体特异性药物靶点

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-10

B. Uhal, David Connolly, Farzaneh Darbeheshti, Y. Zheng, I. Eke, Yutein Chung, L. Samavati

引用次数: 0

Prevention and Control Strategies for the COVID-19 Pandemic 2019冠状病毒病大流行防控策略

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-4

Isfendiyar Darbaz, G. Morris, S. Tüzmen

引用次数: 1

Convalescent Plasma and Antibody Therapy in COVID-19 COVID-19恢复期血浆和抗体治疗

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-8

Didem Rıfkı, Eymen Ü. Kılıç, S. Tüzmen

引用次数: 0

Lessons Learned from COVID-19 and Their Implementations for Future Pandemics 从2019冠状病毒病中吸取的教训及其对未来大流行的实施

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-15

M. Corredor, D. Barh, K. Lundstrom

引用次数: 0

Coronavirus Epidemics and the Current COVID-19 Pandemic 冠状病毒流行和当前的COVID-19大流行

Coronavirus Disease 2019 (COVID-19) Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-1

Aparna Bhardwaj, Prateek Kumar, S. K. Kapuganti, V. Uversky, Rajanish Giri

引用次数: 0